Literature DB >> 21810491

Issues in modern bone histomorphometry.

R R Recker1, D B Kimmel, D Dempster, R S Weinstein, T J Wronski, D B Burr.   

Abstract

This review reports on proceedings of a bone histomorphometry session conducted at the Fortieth International IBMS Sun Valley Skeletal Tissue Biology Workshop held on August 1, 2010. The session was prompted by recent technical problems encountered in conducting histomorphometry on bone biopsies from humans and animals treated with anti-remodeling agents such as bisphosphonates and RANKL antibodies. These agents reduce remodeling substantially, and thus cause problems in calculating bone remodeling dynamics using in vivo fluorochrome labeling. The tissue specimens often contain few or no fluorochrome labels, and thus create statistical and other problems in analyzing variables such as mineral apposition rates, mineralizing surface and bone formation rates. The conference attendees discussed these problems and their resolutions, and the proceedings reported here summarize their discussions and recommendations.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21810491      PMCID: PMC3274956          DOI: 10.1016/j.bone.2011.07.017

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  24 in total

Review 1.  Apoptosis and osteoporosis.

Authors:  R S Weinstein; S C Manolagas
Journal:  Am J Med       Date:  2000-02       Impact factor: 4.965

2.  Mechanical consequences of bone loss in cancellous bone.

Authors:  J C van der Linden; J Homminga; J A Verhaar; H Weinans
Journal:  J Bone Miner Res       Date:  2001-03       Impact factor: 6.741

3.  The label escape error: comparison of measured and theoretical fraction of total bone-trabecular surface covered by single label in normals and patients with osteoporosis.

Authors:  N M Keshawarz; R R Recker
Journal:  Bone       Date:  1986       Impact factor: 4.398

4.  Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee.

Authors:  A M Parfitt; M K Drezner; F H Glorieux; J A Kanis; H Malluche; P J Meunier; S M Ott; R R Recker
Journal:  J Bone Miner Res       Date:  1987-12       Impact factor: 6.741

5.  The label escape error: determination of the active bone-forming surface in histologic sections of bone measured by tetracycline double labels.

Authors:  M P Schwartz; R R Recker
Journal:  Metab Bone Dis Relat Res       Date:  1982

6.  Bone remodeling increases substantially in the years after menopause and remains increased in older osteoporosis patients.

Authors:  Robert Recker; Joan Lappe; K Michael Davies; Robert Heaney
Journal:  J Bone Miner Res       Date:  2004-07-21       Impact factor: 6.741

7.  Histomorphometric evaluation of daily and intermittent oral ibandronate in women with postmenopausal osteoporosis: results from the BONE study.

Authors:  R R Recker; R S Weinstein; C H Chesnut; R C Schimmer; P Mahoney; C Hughes; B Bonvoisin; P J Meunier
Journal:  Osteoporos Int       Date:  2004-01-16       Impact factor: 4.507

8.  Temporal relationship between bone loss and increased bone turnover in ovariectomized rats.

Authors:  T J Wronski; M Cintrón; L M Dann
Journal:  Calcif Tissue Int       Date:  1988-09       Impact factor: 4.333

9.  Trimethoprim-sulfamethoxazole for acute dysuria in women: a single-dose or 10-day course. A double-blind, randomized trial.

Authors:  S D Fihn; C Johnson; P L Roberts; K Running; W E Stamm
Journal:  Ann Intern Med       Date:  1988-03       Impact factor: 25.391

10.  Trabecular bone resorption depth decreases with age: differences between normal males and females.

Authors:  E F Eriksen; L Mosekilde; F Melsen
Journal:  Bone       Date:  1985       Impact factor: 4.398

View more
  43 in total

1.  Histomorphometric interpretation of bone biopsies for the evaluation of osteoporosis treatment.

Authors:  Juliet E Compston
Journal:  Bonekey Rep       Date:  2012-04-04

2.  Effect of Teriparatide on Bone Formation in the Human Femoral Neck.

Authors:  Felicia Cosman; David W Dempster; Jeri W Nieves; Hua Zhou; Marsha Zion; Catherine Roimisher; Yvonne Houle; Robert Lindsay; Mathias Bostrom
Journal:  J Clin Endocrinol Metab       Date:  2016-02-22       Impact factor: 5.958

3.  Pediatric solid organ transplantation and osteoporosis: a descriptive study on bone histomorphometric findings.

Authors:  Inari S Tamminen; Helena Valta; Hannu Jalanko; Sari Salminen; Mervi K Mäyränpää; Hanna Isaksson; Heikki Kröger; Outi Mäkitie
Journal:  Pediatr Nephrol       Date:  2014-02-23       Impact factor: 3.714

Review 4.  Dynamic live imaging of bone: opening a new era with 'bone histodynametry'.

Authors:  Masaru Ishii; Sayumi Fujimori; Takeshi Kaneko; Junichi Kikuta
Journal:  J Bone Miner Metab       Date:  2013-04-02       Impact factor: 2.626

5.  Skeletal accumulation of fluorescently tagged zoledronate is higher in animals with early stage chronic kidney disease.

Authors:  E A Swallow; M W Aref; N Chen; I Byiringiro; M A Hammond; B P McCarthy; P R Territo; M M Kamocka; S Winfree; K W Dunn; S M Moe; M R Allen
Journal:  Osteoporos Int       Date:  2018-06-11       Impact factor: 4.507

Review 6.  Recent developments in metabolic bone diseases: a gnathic perspective.

Authors:  Erich J Raubenheimer; Claudia E Noffke; Hilde D Hendrik
Journal:  Head Neck Pathol       Date:  2014-11-20

7.  Three-dimensional characterization of resorption cavity size and location in human vertebral trabecular bone.

Authors:  M G Goff; C R Slyfield; S R Kummari; E V Tkachenko; S E Fischer; Y H Yi; M G Jekir; T M Keaveny; C J Hernandez
Journal:  Bone       Date:  2012-04-03       Impact factor: 4.398

Review 8.  From histology to micro-CT: Measuring and modeling resorption cavities and their relation to bone competence.

Authors:  Jef Vanderoost; G Harry van Lenthe
Journal:  World J Radiol       Date:  2014-09-28

9.  Diagnostic Accuracy of Biomarkers and Imaging for Bone Turnover in Renal Osteodystrophy.

Authors:  Syazrah Salam; Orla Gallagher; Fatma Gossiel; Margaret Paggiosi; Arif Khwaja; Richard Eastell
Journal:  J Am Soc Nephrol       Date:  2018-03-19       Impact factor: 10.121

10.  Skeletal effects of zoledronic acid in an animal model of chronic kidney disease.

Authors:  M R Allen; N X Chen; V H Gattone; X Chen; A J Carr; P LeBlanc; D Brown; S M Moe
Journal:  Osteoporos Int       Date:  2012-08-21       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.